Leerink

Finally, SVB Leerink raised shares of Regeneron Pharmaceuticals from a “market perform” rating to an “outperform” rating in a research note on Monday, March 27th.

Finally, SVB Leerink started coverage on shares of Intuitive Surgical in a research report on Monday, October 16th.

Finally, Leerink Partners started coverage on Encompass Health in a research note on Wednesday, July 10th.

Finally, Leerink Partnrs downgraded Theravance Biopharma from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 6th.

Finally, Leerink Partnrs raised Zura Bio to a “strong-buy” rating in a report on Monday, November 4th.

Finally, SVB Leerink initiated coverage on shares of Lexicon Pharmaceuticals in a research report on Tuesday, April 30th.

Leerink Partners began coverage on shares of Encompass Health in a report on Wednesday, July 10th.

Leerink Partnrs analyst P. Souda now anticipates that the life sciences company will post earnings of $0.88 per share for the quarter, down from their previous forecast of $0.95.

Leerink Partnrs downgraded agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, January 8th.

Leerink Partnrs downgraded Mirati Therapeutics from an “outperform” rating to a “market perform” rating in a report on Tuesday, November 7th.

Leerink Partnrs raised shares of MannKind to a “strong-buy” rating in a research note on Monday, September 9th.

Leerink Partnrs reaffirmed an “outperform” rating on shares of Pliant Therapeutics in a research note on Monday, October 16th.

Leerink Partnrs reiterated an “outperform” rating on shares of Axonics in a research note on Monday, October 16th.

Oruka Therapeutics, Inc. () – Stock analysts at Leerink Partnrs issued their FY2028 EPS estimates for shares of Oruka Therapeutics in a research note issued on Wednesday, November 13th.

SVB Leerink assumed coverage on shares of Quest Diagnostics in a research report on Monday, February 26th.

SVB Leerink began coverage on CVS Health in a report on Monday, February 26th.

SVB Leerink began coverage on shares of CVS Health in a report on Monday, February 26th.

SVB Leerink began coverage on shares of in a research report report published on Monday, reports.

SVB Leerink started coverage on shares of Arcturus Therapeutics in a report on Monday, August 12th.

SVB Leerink assumed coverage on Amazon.com in a report on Friday, July 24th.